← Leaderboards
William G Kaelin
Dana-Farber Cancer Institute
$28,163,102
Attributed
$28,163,102
Total exposure
18
Grants
15
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.3M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$51,845,239 · 19
By mechanism
P50$30,340,997 · 9
R35$9,761,992 · 1
R01$8,333,387 · 2
R25$2,047,255 · 1
R21$870,788 · 3
R33$478,820 · 1
Top collaborators
- David Mcdermott11 shared
Most similar at Dana-Farber Cancer Institute
Same institution · by research overlap
- William Y Kim$15,134,536
- Othon Iliopoulos$11,620,320
- Zoltan P Arany$25,367,590
- Mark W Kieran$5,389,245
- Andrea F Patenaude$587,078
Others in their field
Top investigators on “Renal Carcinoma”
- David Heimbrook · Leidos Biomedical Research, Inc.$97,125,175
- Ian M Thompson · University Of Texas Hlth Sci Ctr San Ant$23,354,043
- John James McNeil · Hennepin Healthcare Research Institute$22,201,424
- John H Sampson · Duke University$19,179,772
- Richard H Grimm · University Of Minnesota Twin Cities$17,709,591
- Larry Arthur$15,377,757
Research focus
Renal CarcinomaMalignant NeoplasmsBaseCellsTumorResearch PersonnelMutationFundingMutantTranscription FactorMolecularDana-Farber Cancer InstituteMonitorResponseInterestCareerFutureResistanceGenesPharmaceutical PreparationsPathway InteractionsClinical ResearchGenomicsSuccess
Grant awards (95)
DF/HCC Kidney Cancer SPORE (supplement)$1,230,080
P50 · FY2025 · CA
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations$997,800
R35 · FY2025 · CA · contact PI
Project 1:Targeting HIF2 and VHL Synthetic Lethal Interactions in Kidney Cancer$221,564
P50 · FY2025 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,219,550
P50 · FY2024 · CA
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations$947,910
R35 · FY2024 · CA · contact PI
Project 1:Targeting HIF2 and VHL Synthetic Lethal Interactions in Kidney Cancer$280,057
P50 · FY2024 · CA · contact PI
Career Enhancement Program (CEP)$138,603
P50 · FY2024 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,188,219
P50 · FY2023 · CA
The von Hippel-Lindau Tumor Suppressor Gene and Kidney Cancer: Insights into Oxygen Sensing and Treating Cancers Caused by Undruggable Mutations$997,800
R35 · FY2023 · CA · contact PI
Project 1:Targeting HIF2 and VHL Synthetic Lethal Interactions in Kidney Cancer$279,906
P50 · FY2023 · CA · contact PI
Career Enhancement Program (CEP)$138,450
P50 · FY2023 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,148,449
P50 · FY2022 · CA
New Paradigms for Targeting Truncal Driver Mutations$962,850
R35 · FY2022 · CA · contact PI
Project 2 - Targeting IDH-mutant gliomas (Cahill/Kaelin)$292,004
P50 · FY2022 · CA · contact PI
Project 1:Targeting HIF2 and VHL Synthetic Lethal Interactions in Kidney Cancer$240,179
P50 · FY2022 · CA · contact PI
Career Enhancement Program (CEP)$178,371
P50 · FY2022 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,272,484
P50 · FY2021 · CA
New Paradigms for Targeting Truncal Driver Mutations$982,500
R35 · FY2021 · CA · contact PI
Project 2 - Targeting IDH-mutant gliomas (Cahill/Kaelin)$341,279
P50 · FY2021 · CA · contact PI
Project 1:Targeting HIF2 and VHL Synthetic Lethal Interactions in Kidney Cancer$284,061
P50 · FY2021 · CA · contact PI
Career Enhancement Program (CEP)$284,060
P50 · FY2021 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,543,224
P50 · FY2020 · CA
New Paradigms for Targeting Truncal Driver Mutations$982,500
R35 · FY2020 · CA · contact PI
Project 2 - Targeting IDH-mutant gliomas (Cahill/Kaelin)$346,448
P50 · FY2020 · CA · contact PI
Project 1:Targeting HIF2 and VHL Synthetic Lethal Interactions in Kidney Cancer$282,842
P50 · FY2020 · CA · contact PI
Career Enhancement Program (CEP)$194,180
P50 · FY2020 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,139,000
P50 · FY2019 · CA
New Paradigms for Targeting Truncal Driver Mutations$953,025
R35 · FY2019 · CA · contact PI
Project 2 - Targeting IDH-mutant gliomas (Cahill/Kaelin)$331,503
P50 · FY2019 · CA · contact PI
Exploiting Chromatin Alteration to Treat Clear Cell Carcinoma$272,150
P50 · FY2019 · CA · contact PI
Career Development Program$121,356
P50 · FY2019 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,300,000
P50 · FY2018 · CA
New Paradigms for Targeting Truncal Driver Mutations$972,607
R35 · FY2018 · CA · contact PI
Exploiting Chromatin Alteration to Treat Clear Cell Carcinoma$243,260
P50 · FY2018 · CA · contact PI
Career Development Program$142,298
P50 · FY2018 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,300,000
P50 · FY2017 · CA
New Paradigms for Targeting Truncal Driver Mutations$982,500
R35 · FY2017 · CA · contact PI
Exploiting Chromatin Alteration to Treat Clear Cell Carcinoma$243,649
P50 · FY2017 · CA · contact PI
Career Development Program$141,913
P50 · FY2017 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,156,131
P50 · FY2016 · CA
New Paradigms for Targeting Truncal Driver Mutations$982,500
R35 · FY2016 · CA · contact PI
DF/HCC Kidney Cancer SPORE$2,185,000
P50 · FY2015 · CA
The von Hippel-Lindau Tumor Suppressor Protein:Roles in Cancer and Oxygen Sensing$292,284
R01 · FY2015 · CA · contact PI
The RBP2/JARID1A/KDM5A Histone Demethylase as a Potential Drug Target in Cancer$260,276
R01 · FY2015 · CA · contact PI
Molecular Biology in Clinical Oncology Workshop$249,999
R25 · FY2015 · CA · contact PI
The von Hippel-Lindau Tumor Suppressor Protein:Roles in Cancer and Oxygen Sensing$283,515
R01 · FY2014 · CA · contact PI
The RBP2/JARID1A/KDM5A Histone Demethylase as a Potential Drug Target in Cancer$252,468
R01 · FY2014 · CA · contact PI
Molecular Biology in Clinical Oncology Workshop$249,998
R25 · FY2014 · CA · contact PI
Targeting the IDH Pathway$326,224
P50 · FY2013 · CA · contact PI
The von Hippel-Lindau Tumor Suppressor Protein:Roles in Cancer and Oxygen Sensing$274,747
R01 · FY2013 · CA · contact PI
P2 - Treament of VHL-/- clear cell renal carcinoma with HIF2a siRNA$254,796
P50 · FY2013 · CA · contact PI
Molecular Biology in Clinical Oncology Workshop$249,998
R25 · FY2013 · CA · contact PI
The RBP2/JARID1A/KDM5A Histone Demethylase as a Potential Drug Target in Cancer$244,660
R01 · FY2013 · CA · contact PI
The von Hippel-Lindau Tumor Suppressor Protein:Roles in Cancer and Oxygen Sensing$292,284
R01 · FY2012 · CA · contact PI
P2 - Treament of VHL-/- clear cell renal carcinoma with HIF2a siRNA$274,039
P50 · FY2012 · CA · contact PI
The RBP2/JARID1A/KDM5A Histone Demethylase as a Potential Drug Target in Cancer$260,276
R01 · FY2012 · CA · contact PI
Molecular Biology in Clinical Oncology Workshop$249,998
R25 · FY2012 · CA · contact PI
The von Hippel-Lindau Tumor Suppressor Protein:Roles in Cancer and Oxygen Sensing$292,284
R01 · FY2011 · CA · contact PI
The RBP2/JARID1A/KDM5A Histone Demethylase as a Potential Drug Target in Cancer$260,276
R01 · FY2011 · CA · contact PI
P2 - Treament of VHL-/- clear cell renal carcinoma with HIF2a siRNA$260,228
P50 · FY2011 · CA · contact PI
Molecular Biology in Clinical Oncology Workshop$249,998
R25 · FY2011 · CA · contact PI
Functional Analysis of the Von Hippel-Lindau Protein$297,903
R01 · FY2010 · CA · contact PI
P2 - Treament of VHL-/- clear cell renal carcinoma with HIF2a siRNA$273,401
P50 · FY2010 · CA · contact PI
Molecular Biology in Clinical Oncology Workshop$199,999
R25 · FY2010 · CA · contact PI
Functional Analysis of the Von Hippel-Lindau Protein$310,965
R01 · FY2009 · CA · contact PI
Molecular Biology in Clinical Oncology Workshop$303,047
R25 · FY2009 · CA · contact PI
Functional Analysis of the Von Hippel-Lindau Protein$297,903
R01 · FY2009 · CA · contact PI
Treament of VHL-/- clear cell renal carcinoma with HIF2a siRNA$272,039
P50 · FY2009 · CA · contact PI
Functional Analysis of the Von Hippel-Lindau Protein$297,903
R01 · FY2008 · CA · contact PI
Molecular Biology in Clinical Oncology Workshop$294,218
R25 · FY2008 · CA · contact PI
Signal Transduction by the Retinoblastoma Protein$291,851
R01 · FY2008 · CA · contact PI
A Luciferase Fusion Protein Library to Identify & Monitor Ubiquitylation Targets$205,200
R21 · FY2008 · CA · contact PI
Functional Analysis of the Von Hippel-Lindau Protein$297,903
R01 · FY2007 · CA · contact PI
Signal Transduction by the Retinoblastoma Protein$291,851
R01 · FY2007 · CA · contact PI
A Luciferase Fusion Protein Library to Identify & Monitor Ubiquitylation Targets$171,000
R21 · FY2007 · CA · contact PI
Functional Analysis of the Von Hippel-Lindau Protein$306,800
R01 · FY2006 · CA · contact PI
Signal Transduction by the Retinoblastoma Protein$300,567
R01 · FY2006 · CA · contact PI
Real-Time Imaging of Hypoxia based on VHL Activity$240,101
R33 · FY2006 · CA · contact PI
2006 Cancer Model Mechanisms$7,000
R13 · FY2006 · CA · contact PI
Signal Transduction by the Retinoblastoma Protein$307,800
R01 · FY2005 · CA
Functional Analysis of the von Hippel Lindau Protein$283,286
R01 · FY2005 · CA
Real-Time Imaging of Hypoxia based on VHL Activity$238,719
R33 · FY2005 · CA
Using Synthetic Lethality to Select Cancer Drug Targets$153,900
R21 · FY2005 · CA
Signal Transduction by the Retinoblastoma Protein$307,800
R01 · FY2004 · CA
Functional Analysis of the von Hippel Lindau Protein$283,286
R01 · FY2004 · CA
Real-Time Imaging of Hypoxia based on VHL Activity$186,788
R21 · FY2004 · CA
Using Synthetic Lethality to Select Cancer Drug Targets$153,900
R21 · FY2004 · CA
Functional Analysis of the von Hippel Lindau Protein$283,286
R01 · FY2003 · CA
Functional Analysis of the von Hippel Lindau Protein$281,226
R01 · FY2002 · CA
SIGNAL TRANSDUCTION BY THE RETINOBLASTOMA PROTEIN$270,757
R01 · FY2002 · CA
Functional Analysis of the von Hippel Lindau Protein$282,035
R01 · FY2001 · CA
SIGNAL TRANSDUCTION BY THE RETINOBLASTOMA PROTEIN$267,678
R01 · FY2001 · CA
CONFERENCE ON CELL CYCLE 2001$5,000
R13 · FY2001 · CA
SIGNAL TRANSDUCTION BY THE RETINOBLASTOMA PROTEIN$255,215
R01 · FY2000 · CA
FUNCTIONAL ANALYSIS OF THE VON HIPPEL/LINDAU PROTEIN$104,302
R01 · FY2000 · CA